Abstract

Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?

Author(s): Wung Deanna

Issue: Jan/Feb 2013 - Volume 17, Number 1

Page(s): 24-27

Download in electronic PDF format for $75

Abstract

The drugs tadalafil and sildenafil share the same mechanism. Although more research is necessary to solidify the recommendation of the routine use of tadalafil, human and dog data combined with pharmacokinetic data suggest that dogs may be safely treated for canine pulmonary arterial hypertension with tadalafil for the convenience of less frequent dosing, with effects similar to sildenafil. While more costly, the use of tadalafil has positive implications in improving compliance and, therefore, therapeutic outcomes in canine pulmonary arterial hypertension. This article explores the data for the use of tadalafil in canine pulmonary arterial hypertension and provides example compounded preparations.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2013 Pg. 24-27	Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil? Author(s): Wung Deanna
Nov/Dec 2006 Pg. 405-408	Application of Sildenafil for Pulmonary Hypertension in Canines and Foals Author(s): Davidson Gigi S
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Jan/Feb 2012 Pg. 34-41	Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane
Jan/Feb 2010 Pg. 40-45	Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
Nov/Dec 2019 Pg. 492	Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 306	Sildenafil Citrate 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 384-390	Canine Public Servants: Caring for Drug Detection Dogs Author(s): Davidson Gigi S
May/Jun 2016 Pg. 247-249	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Author(s): Nahata Milap C
Sep/Oct 2008 Pg. 392-397	Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Author(s): Mixon William, Helms Scott R
Jul/Aug 2003 Pg. 266-270	Sensitization Therapy for Warts Author(s): Kuntz Rachael
May/Jun 2019 Pg. 236	Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 230	Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 153	Sildenafil 1% Vaginal Cream or Gel Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 154	Sildenafil Vaginal Suppository Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 242-243	Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease Author(s): Patterson Donna, Ford Peter R, Gallon Marlene D
Jan/Feb 2021 Pg. 82-87	Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets Author(s): Cheung Matthew, Zhao Fang, Dave Vivek S
Nov/Dec 2010 Pg. 488-491	Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin Author(s): Rudner Shara, Browne Paul
May/Jun 2002 Pg. 210-215	The Treatment of Canine Atopic Disease Author(s): Davidson Gigi S
Sep/Oct 2021 Pg. 372-377	Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Author(s): Riepl Mike